HLXC: Held by 3 Biotech Hedge Funds (2026) | BiotechEdge

Catalysts Convergence Squeeze SignalsNEW Cash Runway Insiders M&A Research

Home›Companies›Helix Acquisition Corp. III (HLXC)

Helix Acquisition Corp. III

HLXC

Held by 3 specialist biotech funds

High Convergence

3 funds opened new positions.

Shell CompaniesCEO: Bihua ChenIPO: 2025Website ↗

Helix Acquisition Corp. III is a blank-check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operating businesses.

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

4.2/10

3 funds opened new positions●●

No recent insider activity●●

No upcoming catalysts●●

Held by 3 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

3 fund convergence

Cormorant Asset Management

Commodore Capital

Perceptive Advisors

Position history (shares)

Cormorant Asset Management

Commodore Capital

Perceptive Advisors

5 quarters

Position Trend

Aug 6, 2025

$4.5M

1 fund

Aug 14, 2025

$35.1M

2 funds

Nov 14, 2025

0 funds

Feb 17, 2026

0 funds

-100% total institutional value over 11 quarters

Short Interest

Shorts coveringSI declining 3 periods (-52.6%)

Short Shares

Change

-28.8%

Days to Cover

0.1

Settlement

Apr 30, 2026

Short interest over 6 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Activist Filings

SC 13GRA Capital Management7.0%Feb 2, 2026

SC 13G/ARA Capital Management0.0%Nov 15, 2021

SC 13GRTW Investments6.3%Feb 16, 2021

SC 13GRA Capital Management5.9%Feb 16, 2021

Position Details

Cormorant Asset ManagementEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

23 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

ASND1 fund IRD1 fund SLDB1 fund SYRE1 fund TNGX1 fund SION1 fund NBIX1 fund NRIX1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer